Silk Road Medical, Inc. (NASDAQ:SILK) Q1 2022 Results Conference Call May 4, 2022 4:30 PM ET

Company Participants

Erica Rogers - CEO

Lucas Buchanan - CFO

Conference Call Participants

Adam Maeder - Piper Sandler

Danielle Antalffy - SVB Securities

Javier Fonseca - Spartan Capital

Rick Wise – Stifel

Michael Polark - Wolfe Research

Marissa Bych - Gilmartin Group

Operator

Good afternoon, and welcome to Silk Road Medical's First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Marissa Bych, from the Gilmartin Group for a few introductory comments. Please go ahead.

Marissa Bych

Thank you, and thank you all for joining today's call. Joining me are Erica Rogers, Chief Executive Officer; and Lucas Buchanan, Chief Financial Officer and Chief Operating Officer of Silk Road Medical. Earlier today, Silk Road Medical released financial results for the 3 months ended March 31, 2022. A copy of the press release is available on the company's website.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of the federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.

All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, the impact of COVID-19 on our business and prospects for recovery, expense management, expectations for hiring, physician training and adoption, growth in our organization and reimbursement, market opportunity, commercial and international expansion, regulatory approvals and product development are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our annual report on Form 10-K filed with the Securities and Exchange Commission on March 1, 2022.

This conference call contains time-sensitive information and is accurate only as of the live broadcast today, May 4, 2022. Silk Road Medical disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise.